Healthcare Services

Rising Prevalence Of Autoimmune Disorders Driving Growth Of The Market Due To Increasing Cases Of Immune-Mediated Joint Inflammation Continues To Impact The Growth Of The Juvenile Idiopathic Arthritis Diagnostic Market

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Value Outlook For The Juvenile Idiopathic Arthritis Diagnostic Market Through 2030?

The juvenile idiopathic arthritis diagnostic market has shown robust growth in recent years. It is projected to expand from $5.03 billion in 2025 to $5.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. This historical growth is attributable to the increasing prevalence of autoimmune disorders in children, growing awareness of juvenile idiopathic arthritis, improved availability of serological and imaging tests, expansion of pediatric specialty care, and rising use of laboratory diagnostics.

The juvenile idiopathic arthritis diagnostic market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $6.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This projected growth during the forecast period is primarily driven by advancements in molecular and genetic testing technologies, a heightened emphasis on early disease diagnosis, increased investment in pediatric healthcare infrastructure, an escalating demand for personalized medicine approaches, and the expansion of diagnostic services into emerging markets. Key trends expected over the forecast period encompass the early and precise diagnosis of pediatric autoimmune disorders, an expanding application of advanced imaging in jia detection, a surge in the adoption of genetic and biomarker-based testing, a growing need for multimodal diagnostic approaches, and the broadening of specialized pediatric rheumatology diagnostics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23432&type=smp

Which Strategic Drivers Are Supporting The Juvenile Idiopathic Arthritis Diagnostic Market Development?

The anticipated expansion of the juvenile idiopathic arthritis diagnostic market is linked to the rising occurrence of autoimmune conditions. These disorders involve the immune system erroneously targeting healthy cells within the body, leading to inflammation, harm to tissues, and persistent health issues. The surge in autoimmune illnesses stems from an intricate combination of environmental factors, genetic susceptibilities, and shifts in lifestyle. Autoimmune diseases induce juvenile idiopathic arthritis (JIA) by prompting the immune system to wrongly assault the synovial tissue in joints, which results in inflammation and subsequent damage. For example, data from November 2023 by the Multiple Sclerosis International Federation (MSIF), an international UK-based nonprofit dedicated to worldwide MS research and advocacy, indicated that approximately 2.9 million individuals globally had multiple sclerosis, an autoimmune disease, in 2023. Consequently, the growing frequency of autoimmune disorders is fostering the expansion of the juvenile idiopathic arthritis diagnostic market.

Which Segment Groups Define The Juvenile Idiopathic Arthritis Diagnostic Market Landscape?

The juvenile idiopathic arthritis diagnostic market covered in this report is segmented –

1) By Type: Serological Tests, Imaging Tests, Genetic Tests

2) By Technology: Molecular Diagnostics, Immunoassays

3) By Application: Hospital Laboratories, Diagnostic Centres

Subsegments:

1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Complete Blood Count (CBC)

2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound

3) By Genetic Tests: HLA-B27 Genetic Marker Test, Polymerase Chain Reaction (PCR)-Based Testing

What Trends Are Influencing The Future Of The Juvenile Idiopathic Arthritis Diagnostic Market?

Leading corporations within the juvenile idiopathic arthritis diagnostic market are concentrating on strategic alliances to broaden their product portfolios, elevate research competencies, and reinforce their global market foothold. Such strategic partnerships represent collaborations between entities aimed at fostering earlier detection and diagnosis. For example, in November 2024, Augurex Life Sciences Corp., a Canada-based biotechnology firm, joined forces with Quest Diagnostics, a US-based diagnostic services company, with the objective of enhancing the diagnosis and management of rheumatoid arthritis (RA) through the application of the 14-3-3? (eta) biomarker. Under this collaborative arrangement, Quest Diagnostics will validate and introduce a lab-developed test in the United States, which utilizes Augurex’s 14-3-3? biomarker. This test is designed to identify elevated levels of the 14-3-3? protein, a marker associated with rheumatoid arthritis and linked to increased disease severity and potential joint damage.

Which Companies Are Engaged In The Juvenile Idiopathic Arthritis Diagnostic Market Environment?

Major companies operating in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, DiaSorin S.p.A., Sysmex Corporation, Beckman Coulter Inc., BD Biosciences, Agilent Technologies, Merck KGaA, Illumina Inc., Qiagen N.V., Hologic Inc., PerkinElmer Inc., Ortho Clinical Diagnostics, Grifols S.A., Fujirebio, Randox Laboratories

Access The Complete Juvenile Idiopathic Arthritis Diagnostic Market Report:

https://www.thebusinessresearchcompany.com/report/juvenile-idiopathic-arthritis-diagnostic-global-market-report

Which Area Represents The Largest Portion Of The Juvenile Idiopathic Arthritis Diagnostic Market?

North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the juvenile idiopathic arthritis diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Juvenile Idiopathic Arthritis Diagnostic Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=23432&type=smp

Browse Through More Reports Similar to the Global Juvenile Idiopathic Arthritis Diagnostic Market 2026, By The Business Research Company

Osteoarthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Gouty Arthritis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Axial Spondyloarthritis Axspa Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/axial-spondyloarthritis-axspa-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795